Fairvalue-Calculator Fairvalue-Calculator
EN DE

Alpha Teknova, Inc (TKNO) Fair Value & Analysis

Healthcare · US · Market cap $262M

Price$4.89
Fair Value$5.77
Upside+18.0%
Quality95/100
Evidence: Low Range $4.33 – $7.22

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Alpha Teknova, Inc (TKNO) currently trades at $4.89, while our model-based Fair Value estimate is $5.77 — implying the stock looks roughly 18.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was …

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Alpha Teknova, Inc (TKNO) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $5.77 versus a price of $4.89 — about +18% (undervalued). Model-based estimate, not financial advice.
What is the fair value of TKNO?
Our 21-model fair value for Alpha Teknova, Inc is $5.77 (as of Jun 24, 2026), built from audited fundamentals. The current price is $4.89.
What is the quality score of TKNO?
Alpha Teknova, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.